CO124 Indirect Comparison of Efficacy and Safety for Aumolertinib vs Osimertinib in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Abstract
Authors
S Stergiopoulos S King M Curtis SA Dillon R Akehurst D Lee F Guelfucci A Ngami F Bianic Y Li X Ma S Ali VA Miller S Popat